Thursday, 20 April 2017
08:00 | Registration | |||
10:00 | Inauguration | |||
10:10 | Welcome Address by MD, SELECTBIO | |||
10:15 |
| |||
10:45 | Coffee Break | |||
Session 1: Development Strategies for Oral Drug Delivery Formulations | ||||
11:15 | Development Strategies for Fixed Dose Combinations | |||
11:55 | Lipid-Based Drug Delivery Systems as a Solution for Oral Delivery of Challenging Compounds | |||
12:35 | Self-Emulsifying Oral Lipid-Based Nanostructured Systems with Improved Biopharmaceutical Attributes | |||
13:15 | Interactive Session | |||
13:40 | Lunch Break | |||
Session 2: Bioequivalence Strategies for Pharmaceutical Formulations | ||||
14:40 | Is it Possible to Achieve Bio-equivalence Between an Oral Solid Immediate-release and an Analogue Enteric-coated Formulation? | |||
15:20 | Critics on Bioequivalence Studies of FEW DISTINCTIVE Molecules | |||
16:00 | Coffee Break | |||
Session 3: BCS Oriented Biowaiver Strategies for Solid Oral Dosage Forms | ||||
16:20 | “Biowaiver”: An Inexpensive and Time Saving Strategy in the Formulation and Development of BCS Class I and III Oral Solid Dosage Forms | |||
17:00 | Biowaiver Strategies for BCS-1 / BCS-3 Oral Solid Dosage Forms | |||
17:40 | End of First Day of Conference | |||
Friday, 21 April 2017
Session 4: Formulation Development Strategies of Challenging Drug Compounds | ||
09:30 | Accelerating Formulation Development of Protein Drugs: Challenges and Opportunities | |
10:10 | Solubility and Oral Bioavailability Enhancement of Pharmaceuticals: Challenges and Opportunities | |
10:50 | Coffee Break | |
Session 5: Formulation Development Strategies for Delivery of Biologics | ||
11:20 | Current Technical and Regulatory Topics in Formulation and Product Development of Biologics | |
12:00 | Formulation Strategies for a Biologic to Treat Chronic Wounds | |
Session 6: Formulation Strategies for Water Insoluble Drugs | ||
12:40 | Novel Approaches to Formulate Insoluble Potent Drugs as IV Injectable with an Eye to Improve their Therapeutic Efficacy | |
13:20 | Formulation of Water Insoluble Drugs for IV Injections | |
14:00 | Lunch Break | |
Session 7: Academic Innovation Oral Presentations: Novel and Nanostructured Dug Delivery Systems | ||
15:10 | Reconnoitering Scaffolds as Sustained Release Drug Delivery Carriers | |
15:20 | Development of Supersaturated Drug Delivery System: Effect of Polymers and Implications on Supersaturation, Nucleation and Crystal Growth | |
15:30 | Novel Lipid Nanoformulation of Artemether-Lumefantrine Combination for Oral Malaria Therapy | |
15:30 | Formulation of Nano Lipid Vesicles for the Treatment of Rheumatoid Arthritis | |
15:40 | Lymphatic system Targeted Lipid Nanocarriers: A Promising Approach for Oral Treatment of Breast Cancer | |
15:50 | Lyophilized Phytosomal Nano Carriers of Rutin for Hepatoprotective Activity | |
16:00 | Antigen Loaded Microparticles as Novel Mucosal Vaccine Delivery Systems against Airborne Pathogens | |
16:10 | NanoMicide Gel and its Delivery Device: An Alternative to Condoms for Prevention of UAI Associated HIV | |
16:20 | Novel Formulation of Class-II and IV Drugs to Improve Bioavailablity | |
16:30 | Novel Anti-Oxidant Enzyme Delivery System for Prevention of Cataract | |
16:40 | Oral Presentations Awards | |
16:45 | Closing Remarks | |
17:00 | END OF CONFERENCE | |